Dudediligence.

Daré Bioscience, Inc

DARENASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

15.2M

on 2026-06-30, from 8.55M on 2024-09-30 10-Q ↗

Counts before 2024-09-30 are left out: the count went from 102.6M on 2024-06-30 to 8.55M on 2024-09-30, a change no split on file explains.

a raise that quarter, at its price

5M10M15MSep2024DecMar2025JunSepDecMar2026Jun

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

5 of its filings are not read yet.

Warrants

10.01M

Warrants of every class as tagged in the XBRL facts on 2023-09-30. 10-Q ↗

Cash

4.5 quarters

$12.6M on 2026-06-30 ÷ $2.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-14Public offering4,085,687$1.37$6.0M424B5 ↗